Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 1;5(6):e007470.
doi: 10.1136/bmjopen-2014-007470.

Risk of bladder cancer in patients with diabetes: a retrospective cohort study

Affiliations

Risk of bladder cancer in patients with diabetes: a retrospective cohort study

Maria E Goossens et al. BMJ Open. .

Abstract

Objective: The objective of this study was to examine the association between diabetes, and both urinary bladder cancer (UBC) risk and mortality.

Methods: We conducted a retrospective cohort study using data from the UK Clinical Practice Research Datalink (CPRD) linked to the Office of National Statistics (ONS). Patients diagnosed with diabetes mellitus type 1 or 2, or using antidiabetic drugs (ADDs), were compared to matched non-diabetic controls. Cox proportional hazards models were used to estimate the risk and mortality of UBC. We adjusted for age, sex, smoking status and body mass index.

Results: The cohort included 329,168 patients using ADD, and 307,315 controls with 1295 and 1071 patients, respectively, diagnosed as having UBC during follow-up. The adjusted HRs of UBC were 0.77 (95% CI 0.57 to 1.05) and 1.04 (95% CI 0.96 to 1.14) for type 1 and 2 diabetes, respectively. These results were similar if we restricted our analysis to an inception cohort. We noticed a small increased risk during the first year after diagnosis (HR=1.26 (95% CI 1.05 to 1.52)), which could be explained by detection bias. There was no influence of the severity of diabetes as measured by the glycated haemoglobin. Mortality of UBC was not increased for patients with either type 1 (HR=0.95 (95% CI 0.39 to 2.34)) or type 2 diabetes (HR=1.16 (95% CI 0.91 to 1.46)).

Conclusions: Neither the risk of UBC nor the mortality from UBC was increased in patients with type 1 and patients with type 2 diabetes in the CPRD data.

Keywords: EPIDEMIOLOGY; mortality.

PubMed Disclaimer

References

    1. International Diabetes Federation. IDF diabetes atlas. 6th edn Brussels, Belgium: International Diabetes Federation, 2013. http://www.idf.org/diabetesatlas
    1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4–14. 10.1016/j.diabres.2009.10.007 - DOI - PubMed
    1. Ngwana G, Aerts M, Truyers C et al. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting. Diabetes Res Clin Pract 2012;97:331–6. 10.1016/j.diabres.2012.02.002 - DOI - PubMed
    1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer, 2013. http://globocan.iarc.fr.
    1. Goossens ME, Buntinx F, Zeegers MP. Aetiology, demographics and risk factors for bladder cancer. In: The Oxford textbook of surgery. Oxford University Press (OUP) 2015, in press.

Publication types

LinkOut - more resources